Not doing so may lead to unwanted side effects, loss of muscle mass, and poor markers of health other than weight
Additionally, GLP-1 therapies suppress glucagon, a hormone that normally elevates blood sugar, further enhancing glucose regulation
The most commonly reported side effects are mild injection site reactions and occasional headache, both of which are generally transient
While the effects of GIP receptor antagonism on these outcomes remain unknow, GIPR knockout mice have been shown to exhibit impaired learning and memory, as well as reduced synaptic plasticity (111)
The review emphasized that optimal cold-chain management from manufacturing until the point of delivery to people with diabetes should always be maintained, a principle equally important for GLP-1 travelers
This diagram from Qin et al